Published in Vaccine Weekly, August 18th, 2004
According to recent research from Belgium and the United States, "We have previously reported on a universal human influenza A vaccine, based on the external domain of the transmembrane viral M2-protein (M2e). M2-protein is scarcely present on the virus but is abundantly expressed on virus-infected cells. The external domain, M2e, is 23-amino acids long and as such weakly immunogenic. But when presented on an appropriate carrier, such as hepatitis B virus core (HBc) particles, it induces a high titer antibody response that in mice effectively protects against a potentially lethal influenza...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly